Across 275 structured interviews with San Diego in-house counsel over 36 months, Sartori's cohort shows 48% of genomics-adjacent respondents said their last move was between a sequencing OEM, a clinical institute, and a medtech or diagnostics legal team. In 12 closed in-house searches in San Diego over 24 months, 9 offers went to lawyers already based in California, Sartori's mandate telemetry shows. The commercial seat Illumina posted on 18 August 2026 drafts customer, vendor, and collaborator agreements, sits with finance and product on go-to-market, and runs M&A diligence and post-close integration. Feeders are already in-house more often than they are law-firm exits.
A companion regulatory-and-quality director posting dated 4 June 2026 covered FDCA, FDA device rules, EU IVDR, inspections, labeling, and quality-system counsel for RUO, IVD, and diagnostics. The Chief Legal Officer remit added government affairs, intellectual property, compliance, and corporate-secretary work after GRAIL's 24 June 2024 distribution and the China instrument bar. A chief legal officer at a clinical genomics institute said the seat needed someone who had already negotiated CLIA, CAP, and payer coverage files. Public biographies on the 2026 CLO appointment list 15-year commercial or regulatory paths with seven to ten years of management, plus in-house commercial time at medtech or diagnostics companies. California bar or in-house registration is required on the live commercial director role; public-sector procurement is listed as a plus.